Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

IMW 2019 | Amyloidosis: diagnosis and stem cell transplantation

Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, Morie Gertz, MD, MACP, Mayo Clinic College of Medicine, Rochester, MN, and Raymond Comenzo MD, Tufts University School of Medicine, Boston, MA, discuss the current treatment approach to amyloidosis. They explain the importance of accurate diagnosis, the necessity of determining the amyloid precursor protein, and debate whether stem cell transplant is still useful in the age of novel therapies. This roundtable was held at the International Myeloma Workshop (IMW) 2019, in Boston, MA.